Discovery of Dual Axl/VEGF-R2 Inhibitors As Potential Anti-Angiogenic and Anti-Metastatic Drugs for Cancer Chemotherapy
Bioorganic & Medicinal Chemistry Letters(2017)
摘要
Axl tyrosine kinase has been shown to be involved in multiple pathways contributing to tumor development, angiogenesis, and metastasis. High Axl expression has been observed in many human tumors where it appears to confer aggressive tumor behavior. Here we present several series of dual Axl-VEGF-R2 kinase inhibitors based on extensive optimization of an acyl diaminotriazole. It was hypothesized that dual inhibition of these two receptor tyrosine kinases may have a synergistic affect in inhibiting tumor angiogenesis and metastasis. One of these molecules, R916562 showed comparable activity to Sunitinib in two mouse tumor xenograft models and a mouse corneal micropocket model.
更多查看译文
关键词
Axl tyrosine kinase inhibitor,VEGF-R2,Diaminotriazole
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要